Design and Rationale of the COLT Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 940 participants.

Also called NCT07432529

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 940 participants (planned count) (from the registry)
Sponsor
Azienda Sanitaria Locale ASL 6, Livorno (from the registry)
Registry
  • NCT NCT07432529
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07432529. Randomized; quadruple masking; primary purpose prevention. Start 2026-06-01 (anticipated); primary completion 2027-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Design and Rationale of the COLT Study
Acronym
COLT
Condition
Venous Thrombosis Deep (Limbs)
Condition
Post-thrombotic Syndrome
Condition
Venous Thromboembolism (VTE)
Condition
Venous Insufficiency
Intervention (Drug)
Colchicine 0.5 MG Oral Tablet
Intervention (Drug)
Placebo
Lead sponsor
Azienda Sanitaria Locale ASL 6, Livorno (class: other government)

Record details

Record id
cardio:ct-nct07432529
Content hash
c114249751eb4e50ccfdba65ec37de239f545a353051dade927b746f4a6c7d73